What were the most commonly reported adverse reactions to teduglutide in clinical studies of patients with short bowel syndrome?

In short bowel syndrome studies, teduglutide’s most commonly reported adverse reactions were abdominal pain and distension (45%), respiratory tract infections (28%), nausea (26%), injection-site reactions (26%), headache (16%) and vomiting (14%); approximately 38% of treated patients with a stoma experienced gastrointestinal stoma complications.